Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
A novel human multiple myeloma cell line with genetic abnormality of 1q21 gains only and CKS1B overexpression
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
PDF) Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
plus dead) labeled
Myeloma Explained | Haematology | Oncology | onthewards
A novel xenograft mouse model for testing approaches targeting human kappa light-chain diseases | Gene Therapy
A) Ultrastructure of NCI-H929 | Download Scientific Diagram
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
plus dead) labeled
Establishment of Five Human Myeloma Cell Lines
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
Goat anti-Human Lambda Light Chain Secondary Antibody (NBP1-72788): Novus Biologicals
Upregulated expression and function of the α4β1 integrin in multiple myeloma cells resistant to bortezomib - Sevilla‐Movilla - 2020 - The Journal of Pathology - Wiley Online Library
-Immunocytochemistry-Immunofluorescence-NBP2-34258-img0004.jpg "Kappa Light Chain Antibody (HP6053 + L1C1) (NBP2-34258): Novus Biologicals")
Kappa Light Chain Antibody (HP6053 + L1C1) (NBP2-34258): Novus Biologicals
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 | Haematologica
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia
NCI-H929细胞ATCC CRL-9068细胞H929人骨髓瘤细胞株购买价格、培养基、培养条件、细胞图片、特征等基本信息_生物风
